Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Lapa

Showing results (31-40 of 317) with videos related to

Pageof 32
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2017
Dose Mapping After Endoradiotherapy with <sup>177</sup>Lu-DOTATATE/DOTATOC by a Single Measurement After 4 DaysHeribert Hänscheid, Constantin Lapa, Andreas K Buck, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE/-TOCHeribert Hänscheid, Constantin Lapa, Andreas K Buck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2021
Intraindividual comparison of [<sup>177</sup>Lu]Lu-DOTA-EB-TATE and [<sup>177</sup>Lu]Lu-DOTA-TOCHeribert Hänscheid, Philipp E Hartrampf, Andreas Schirbel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 2025
ML Prediction of Recurrence in Pediatric Thyroid Cancer: MET Cohort Analysis Using XGBoost and SHAPAntje Redlich, Elisabeth Pfaehler, Marina Kunstreich, et al.
EJNMMI Research|July 8, 2023
Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogsNadine Holzleitner, Thomas Günther, Amira Daoud-Gadieh, et al.
Endocrine|April 27, 2021
Thyroid incidentalomas with increased focal <sup>18</sup>F-FDG uptake in <sup>18</sup>F-FDG PET/CT of a patient with multiple primary cancersPatrick W Mihatsch, Matthias Beissert, Thorsten A Bley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2019
False-negative <sup>18</sup>F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptakePhilipp E Hartrampf, Anna Katharina Seitz, Markus Krebs, et al.
Clinical Nuclear Medicine|March 6, 2015
Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignanciesChristian Linz, Urs D A Müller-Richter, Stefan Kircher, et al.
European Journal of Haematology|March 12, 2014
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptomsConstantin Lapa, Markus Knott, Leo Rasche, et al.
Plos One|October 27, 2015
Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and HistopathologyBenjamin Kläsner, Niels Buchmann, Jens Gempt, et al.
Pageof 32

Showing results (31-40 of 317) with videos related to

Sort By:
Pageof 32
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2017
Dose Mapping After Endoradiotherapy with <sup>177</sup>Lu-DOTATATE/DOTATOC by a Single Measurement After 4 DaysHeribert Hänscheid, Constantin Lapa, Andreas K Buck, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE/-TOCHeribert Hänscheid, Constantin Lapa, Andreas K Buck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2021
Intraindividual comparison of [<sup>177</sup>Lu]Lu-DOTA-EB-TATE and [<sup>177</sup>Lu]Lu-DOTA-TOCHeribert Hänscheid, Philipp E Hartrampf, Andreas Schirbel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 2025
ML Prediction of Recurrence in Pediatric Thyroid Cancer: MET Cohort Analysis Using XGBoost and SHAPAntje Redlich, Elisabeth Pfaehler, Marina Kunstreich, et al.
EJNMMI Research|July 8, 2023
Investigation of the structure-activity relationship at the N-terminal part of minigastrin analogsNadine Holzleitner, Thomas Günther, Amira Daoud-Gadieh, et al.
Endocrine|April 27, 2021
Thyroid incidentalomas with increased focal <sup>18</sup>F-FDG uptake in <sup>18</sup>F-FDG PET/CT of a patient with multiple primary cancersPatrick W Mihatsch, Matthias Beissert, Thorsten A Bley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2019
False-negative <sup>18</sup>F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptakePhilipp E Hartrampf, Anna Katharina Seitz, Markus Krebs, et al.
Clinical Nuclear Medicine|March 6, 2015
Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignanciesChristian Linz, Urs D A Müller-Richter, Stefan Kircher, et al.
European Journal of Haematology|March 12, 2014
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptomsConstantin Lapa, Markus Knott, Leo Rasche, et al.
Plos One|October 27, 2015
Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and HistopathologyBenjamin Kläsner, Niels Buchmann, Jens Gempt, et al.
Pageof 32